Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Church & Dwight Co. Inc.

Latest From Church & Dwight Co. Inc.

C&D Investors, Analysts Not On Same Page

Share price’s recent ride doesn’t track with analysts’ regard for C&D’s results and outlook.

Consumer Sales & Earnings

Church & Dwight Cuts ‘Power’ Brands To Seven While Reporting, Forecasting Bigger Results

Health, personal and household care product marketer says raising its annual guidance model from 3% organic growth to 4% driven by expectations for international sales growth, a return to volume-driven sales growth and outlook for Hero and TheraBreath brands.

Consumer Business Strategies

US Q4 Consumer Health Earnings Preview: Supply Chain Disruption Returns, Opill Launch Waits

Attacks on shipping since November in the Red Sea lead shipping lines to re-route vessels south of Africa, spiking shipping costs. Perrigo began 2024 saying it expects sales of Opill oral contraceptive to start early in the first quarter, but now expects to start late in the quarter.

Consumer Sales & Earnings

Volume Returns As Church & Dwight Sales Driver With Economic Headwinds Not Ready To Leave

Higher costs and interest rates due to inflation as well as higher credit card debt point toward consumers spending less in areas including health, personal and household care products. C&D is “well-positioned for this trade down” with 40% of its portfolio in value products, says CEO Matthew Farrell.

Consumer Sales & Earnings
See All

Company Information

  • Industry
  • Diversified
  • Medical Devices
  • Pharmaceuticals
    • OTC, Consumer